China Shineway Pharmaceutical Group Limited (2877.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In HKD
Address
No. 168 Shiluan Street
Shijiazhuang, 051430
China
Phone
86 31 1880 30066
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
3220
First IPO Date
December 02, 2004
| Name | Title | Pay | Year Born |
| King Kuen Hung | Director of Investor Relation | 38,202 | 1966 |
| Huimin Li | Executive Director | 2.43M | 1968 |
| Yunxia Xin | Co-Founder & Executive Director | 3.67M | 1963 |
| Zhenjiang Li | Co-Founder & Executive Chairman | 8.86M | 1955 |
| Bun Ching Lee | Financial Controller & Company Secretary | 0 | 1973 |
As an investment holding enterprise, China Shineway Pharmaceutical Group Limited is dedicated to the development, production, and sale of traditional Chinese medicines throughout the People's Republic of China and Hong Kong. Its extensive product range includes modern Chinese pharmaceuticals delivered as soft capsules, granular preparations, and injectable forms, alongside specialized Traditional Chinese Medicine (TCM) Formula Granules. These offerings cater to a broad spectrum of therapeutic needs, such as cardiovascular and cerebrovascular health, anti-viral applications, orthopedic conditions, pediatric ailments, gynecological care, and gastrointestinal issues. Furthermore, the company is involved in the trading of agricultural commodities. Founded in 2004, its headquarters are situated in Shijiazhuang, PRC, and it functions as a subsidiary of Forway Investment Limited.